[Development of a suppository form of the interferon inducer poludan and potentiation of its action by hyaluronic acid].
A promising dosage form of interferon inductor poludan has been developed for the treatment of patients with genital herpes and ophthalmic herpes: suppositoria. High interferon-producing and antiviral activity of poludan in suppositoria is potentiated by hyaluronic acid and antioxidants.
Barinskiĭ
I F
IF
Alimbarova
L M
LM
Samoĭlenko
I I
II
Gubanova
E I
EI
Kosiakova
N P
NP
Fadeeva
L L
LL
Petracheva
O N
ON
Semenova
T B
TB
Kasparov
A A
AA
D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004357:Drug Synergism; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007369:Interferon Inducers / Q000008:administration & dosage* / Q000627:therapeutic use; D016849:Keratitis, Herpetic / Q000188:drug therapy*; D011131:Polyribonucleotides / Q000008:administration & dosage* / Q000627:therapeutic use; D013488:Suppositories
D000998:Antiviral Agents; D007369:Interferon Inducers; D011131:Polyribonucleotides; D013488:Suppositories; C044366:poludan; D006820:Hyaluronic Acid